Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure

被引:373
作者
Gundewar, Susheel [1 ]
Calvert, John W. [1 ]
Jha, Saurabh [1 ]
Toedt-Pingel, Iris [1 ]
Ji, Sang Yong [1 ]
Nunez, Denise [1 ]
Ramachandran, Arun [1 ]
Anaya-Cisneros, Mauricio [1 ]
Tian, Rong [3 ]
Lefer, David J. [1 ,2 ]
机构
[1] Albert Einstein Coll Med, Dept Med, Div Cardiol, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA
[3] Brigham & Womens Hosp, Div Cardiovasc Med, Nucl Magnet Resonance Lab Physiol Chem, Boston, MA 02115 USA
关键词
myocardial ischemia; heart failure; metformin; nitric oxide; ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHESIS; MITOCHONDRIAL BIOGENESIS; MYOCARDIAL-INFARCTION; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; THERAPY; DISEASE; INSULIN; ASSOCIATION;
D O I
10.1161/CIRCRESAHA.108.190918
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical studies have reported that the widely used antihyperglycemic drug metformin significantly reduces cardiac risk factors and improves clinical outcomes in patients with heart failure. The mechanisms by which metformin exerts these cardioprotective effects remain unclear and may be independent of antihyperglycemic effects. We tested the hypothesis that chronic activation of AMP-activated protein kinase ( AMPK) with low-dose metformin exerts beneficial effects on cardiac function and survival in in vivo murine models of heart failure. Mice were subjected to permanent left coronary artery occlusion or to 60 minutes left coronary artery occlusion followed by reperfusion for 4 weeks. High-resolution, 2D echocardiography was performed at baseline and 4 weeks after myocardial infarction to assess left ventricular dimensions and function. Metformin ( 125 mu g/kg) administered to mice at ischemia and then daily improved survival by 47% ( P < 0.05 versus vehicle) at 4 weeks following permanent left coronary artery occlusion. Additionally, metformin given at reperfusion and then daily preserved left ventricular dimensions and left ventricular ejection fraction ( P < 0.01 versus vehicle) at 4 weeks. The improvement in cardiac structure and function was associated with increases in AMPK and endothelial nitric oxide synthase ( eNOS) phosphorylation, as well as increased peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1 alpha expression in cardiac myocytes. Furthermore, metformin significantly improved myocardial cell mitochondrial respiration and ATP synthesis compared to vehicle. The cardioprotective effects of metformin were ablated in mice lacking functional AMPK or eNOS. This study demonstrates that metformin significantly improves left ventricular function and survival via activation of AMPK and its downstream mediators, eNOS and PGC-1 alpha, in a murine model of heart failure. ( Circ Res. 2009; 104: 403-411.)
引用
收藏
页码:403 / U221
页数:16
相关论文
共 39 条
  • [1] Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus
    Abbasi, F
    Chu, JW
    McLaughlin, T
    Lamendola, C
    Leary, ET
    Reaven, GM
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (02): : 159 - 164
  • [2] Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle
    Arany, Z
    He, HM
    Lin, JD
    Hoyer, K
    Handschin, C
    Toka, O
    Ahmad, F
    Matsui, T
    Chin, S
    Wu, PH
    Rybkin, II
    Shelton, JM
    Manieri, M
    Cinti, S
    Schoen, FJ
    Bassel-Duby, R
    Rosenzweig, A
    Ingwall, JS
    Spiegelman, BM
    [J]. CELL METABOLISM, 2005, 1 (04) : 259 - 271
  • [3] Drug therapy - Metformin
    Bailey, CJ
    Turner, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) : 574 - 579
  • [4] Cardiac imaging for risk stratification in diabetes
    Bax, Jeroen J.
    Inzucchi, Silvio E.
    Bonow, Robert O.
    Schuijf, Joanne D.
    Freeman, Michael R.
    Barrett, Eugene J.
    [J]. DIABETES CARE, 2007, 30 (05) : 1295 - 1304
  • [5] AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B
    Bertrand, L
    Ginion, A
    Beauloye, C
    Hebert, AD
    Guigas, B
    Hue, L
    Vanoverschelde, JL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (01): : H239 - H250
  • [6] Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling
    Calvert, John W.
    Gundewar, Susheel
    Jha, Saurabh
    Greer, James J. M.
    Bestermann, William H.
    Tian, Rong
    Lefer, David J.
    [J]. DIABETES, 2008, 57 (03) : 696 - 705
  • [7] Inhibition of N-ethylmaleimide-sensitive factor protects against myocardial ischemia/reperfusion injury
    Calvert, John W.
    Gundewar, Susheel
    Yamakuchi, Munekazu
    Park, Pierce C.
    Baldwin, William M.
    Lefer, David J., III
    Lowenstein, Charles J.
    [J]. CIRCULATION RESEARCH, 2007, 101 (12) : 1247 - 1254
  • [8] Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase
    Davis, BJ
    Xie, ZL
    Viollet, B
    Zou, MH
    [J]. DIABETES, 2006, 55 (02) : 496 - 505
  • [9] Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-α/PGC-1α gene regulatory pathway
    Duncan, Jennifer G.
    Fong, Juliet L.
    Medeiros, Denis M.
    Finck, Brian N.
    Kelly, Daniel P.
    [J]. CIRCULATION, 2007, 115 (07) : 909 - 917
  • [10] Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function
    Elrod, John W.
    Calvert, John W.
    Morrison, Joanna
    Doeller, Jeannette E.
    Kraus, David W.
    Tao, Ling
    Jiao, Xiangying
    Scalia, Rosario
    Kiss, Levente
    Szabo, Csaba
    Kimura, Hideo
    Chow, Chi-Wing
    Lefer, David J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (39) : 15560 - 15565